Voltage-dependent anion channel involved in the -synuclein-induced dopaminergic neuron toxicity in rats

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 3, 2013, Pages 170-178

  Lu, Lingling ^a   Zhang, Chunyan ^a   Cai, Qing ^a   Lu, Qiang ^a   Duan, Chunli ^a   Zhu, Yuangang ^a   Yang, Hui ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

synuclein; electron microscope; mitochondrial dysfunction; Parkinson's disease; subcellular localization

Indexed keywords

ALPHA SYNUCLEIN; CARRIER PROTEIN; DOPAMINE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; VDAC1 PROTEIN, RAT; VOLTAGE DEPENDENT ANION CHANNEL 1;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN; DOPAMINERGIC NERVE CELL; METABOLISM; MITOCHONDRION; PATHOLOGY; PERMEABILITY; RAT; SPRAGUE DAWLEY RAT;

ALPHA-SYNUCLEIN; ANIMALS; APOPTOSIS; BRAIN; DOPAMINE; DOPAMINERGIC NEURONS; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84874386672     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms114     Document Type: Article

References (34)

1. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A and Pike B, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276: 2045-2047.
2. Arima K, Uéda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara Y and Kawai M. Immunoelectron microscopic demonstration of NACP/a-synuclein- epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 1998, 808: 93-100.
3. Spillantini MG, Crowther RA, Jakes R, Hasegawa M and Goedert M. Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 1998, 95: 6469-6473.
4. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY and Rojanowski JQT, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998, 152: 879-884.
5. Sung JY, Lee HJ, Jeong EI, Oh Y, Park J, Kang K and Chunga KC. a-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells. Neurosci Lett 2007, 416: 289-293.
6. Nakamura K, Nemani VM, Azarbal F, Skibinski G, Levy JM, Egami K and Munishkina L, et al. Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem 2011, 286: 20710-20726.
7. Li WW, Yang R, Guo JC, Ren HM, Zha XL, Cheng JS and Cai DF. Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 2007, 18: 1543-1546.
8. Petit-Paitel A, Brau F, Cazareth J and Chabry J. Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neurons. PLoS ONE 2009, 4: e5491.
9. Yao Z and Wood NW. Cell death pathways in Parkinson's disease: role of mitochondria. Antioxid Redox Signal 2009, 11: 2135-2149.
10. Ardúno DM, Esteves AR, Cardoso SM and Oliveira CR. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease. Neurochem Int 2009, 55: 341-348.
11. Schapira AH. Mitochondrial pathology in Parkinson's disease. Mt Sinai J Med 2011, 78: 872-881.
12. Xie W, Wan OW and Chung KK. New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson's disease. Biochim Biophys Acta 2010, 1802: 935-941.
13. Vives-Bauza C and Przedborski S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol Med 2011, 17: 158-165.
14. Gincel D and Shoshan-Barmatz V. Glutamate interacts with VDAC and modulates opening of the mitochondrial permeability transition pore. J Bioenerg Biomembr 2004, 36: 179-186.
15. Schinzel AC, Takeuchi O, Huang Z, Fisher JK, Zhou Z, Rubens J and Hetz C, et al. Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci USA 2005, 102: 12005-12010.
16. Beutner G, Rück A, Riede B and Brdiczka D. Complexes between porin, hexokinase, mitochondrial creatine kinase and adenylate translocator display properties of the permeability transition pore. Implication for regulation of permeability transition by the kinases. Biochim Biophys Acta 1998, 1368: 7-18.
17. Rodriguez-Enriquez S, He L and Lemasters JJ. Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int J Biochem Cell Biol 2004, 36: 2463-2472.
18. Yu S, Li X, Liu G, Han J, Zhang C, Li Y and Xu S, et al. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 2007, 145: 539-555.
19. Maingay M, Romero-Ramos M and Kirik D. Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease. J Neurochem 2004, 91: 451-461.
20. St Martin JL, Klucken J, Outeiro TF, Nguyen P, Keller-McGandy C, Cantuti-Castelvetri I and Grammatopoulos TN, et al. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra. J Neurochem 2007, 100: 1449-1457.
21. Mochizuki H, Yamada M and Mizuno Y. Alpha-synuclein overexpression model. J Neural Transm 2006, 70: 281-284.
22. Yamada M, Iwatsubo T, Mizuno Y and Mochizuki H. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease. J Neurochem 2004, 91: 451-461.
23. Hsu LJ, Sagara Y, Arroyo A, Rockenstein E, Sisk A, Mallory M and Wong J, et al. alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am J Pathol 2000, 157: 401-410.
24. Hunter DR and Haworth RA. The Ca2\+-induced membrane transition in mitochondria: the protective mechanisms. Arch Biochem Biophys 1979, 195: 453-459.
25. Haworth RA and Hunter DR. The Ca2\+-induced membrane transition in mitochondria. II. Nature of the Ca2\+ trigger site. Arch Biochem Biophys 1979, 195: 460-467.
26. Crompton M, Costi A and Hayat L. Evidence for the presence of a reversible Ca2\+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J 1987, 245: 915-918.
27. Devi L, Raghavendran V, Prabhu BM, Avadhani NG and Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impairs complex I in human dopaminergic neuronal cultures and Parkinson's disease brain. J Biol Chem 2008, 283: 9089-9100.
28. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 2009, 46: 821-831.
29. Tsujimoto Y and Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 2007, 12: 835-840.
30. Chinta SJ, Mallajosyula JK, Rane A and Andersen JK. Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci Lett 2010, 486: 235-239.
31. Lynch-Day MA, Mao K, Wang K, Zhao M and Klionsky DJ. The role of autophagy in Parkinson's disease. Cold Spring Harb Perspect Med 2012, 2: a009357.
32. Yuko H, Dongchon K and Tomotake K. The physiological role of mitophagy: new insights into phosphorylation events. Int J Cell Biol 2012, 2012: 1-3.
33. Sampaio-Marques B, Felgueiras C, Silva A, Rodrigues M, Tenreiro S, Franssens V and Reichert AS, et al. SNCA (a-synuclein)-induced toxicity in yeast cells is dependent on sirtuin 2 (Sir2)-mediated mitophagy. Autophagy 2012, 8: 1494-1509.
34. Lemasters J, Qian T, He L, Kim JS, Elmore SP, Cascio WE and Brenner DA. Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 2002, 4: 769-781.